About Cellipse

About company

ELLIPSE was incorporated in early 2013 by its three co-founders Dr Laurence Lafanechère, Dr Renaud Prudent and Fabrice Paublant to take the LIMINIB program from pre-clinical proof-of-concept to a first-in-class LIM Kinase inhibitor.CELLIPSE and Institut Albert Bonniot (), Grenoble won the 2013 Preuve de Concept Contest from Cancéropole CLARA ().Leveraging internal know-how in high content phenotypic screening and in small molecule lead optimization, CELLIPSE co-founders are building a leading Biotech company in the field of small molecule agents regulating the cytoskeleton with application in oncology and beyond (Central Nervous System, Ophtalmology…).